Abstract
The European market for cardiac rhythm management devices sold in France,
Germany, Italy, Spain, and the UK, was valued in excess of $1.5 billion in
2006.
This market is comprised of pacemakers, implantable cardioverter
defibrillators, and cardiac resynchronization therapy devices.
|